Hyperphosphatemia in Chronic Kidney Disease Patients On Dialysis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2015-06-12
FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)
FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) from Fresenius Medical Care Renal Therapies Group, LLC, pote…